| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |